Apolipoprotein E (APOE) increases the risk for Alzheimer's disease (ɛ4 allele) and cerebral amyloid angiopathy (ɛ2 and ɛ4), but its role in small vessel disease (SVD) is debated. Here we studied the effects of APOE on white matter hyperintensity volume (WMHV) in CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a nonamyloidogenic angiopathy and inherited early-onset form of pure SVD. Four hundred and eighty-eight subjects were recruited through a multicenter consortium. Compared with APOE ɛ3/ɛ3, WMHV was increased in APOE ɛ2 (P=0.02) but not APOE ɛ4. The results remained significant when controlled for genome-wide genetic background variation. Our findings suggest a modifying influence of APOE ɛ2 on WMHV caused by pure SVD.Journal of Cerebral Blood Flow & Metabolism advance online publication, 29 April 2015; doi:10.1038/jcbfm.2015.85.
Scheda prodotto non validato
Scheda prodotto in fase di analisi da parte dello staff di validazione
|Titolo:||APOE ɛ2 is associated with white matter hyperintensity volume in CADASIL|
|Citazione:||Gesierich, B., Opherk, C., Rosand, J., Gonik, M., Malik, R., Jouvent, E., et al. (2016). APOE ɛ2 is associated with white matter hyperintensity volume in CADASIL. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 36(1), 199-203.|
|Appare nelle tipologie:||1.1 Articolo in rivista|
File in questo prodotto: